Top 47 alternative sites to lumosa.com.tw
-
jubilanttx.com
-
lineagecell.com
-
incytebiosciences.uk
-
incytebiosciences.ca
-
egetis.com
-
oncternal.com
-
cardiffoncology.com
-
bioeclipse.com
-
otmbiotech.co
-
arcturusrx.com
-
formatherapeutics.com
-
anaptysbio.com
-
abcentra.com
-
inmedpharma.com
-
vtvtherapeutics.com
-
effrx.com
-
madrigalpharma.com
-
logicbio.com
-
algiax.com
-
aurismedical.com
-
qtvascular.com
-
bonetherapeutics.com
-
pharnext.com
-
newtonbiocapital.com
-
translate.bio
-
prilenia.com
-
summittxinc.com
-
byondis.com
-
interna-technologies.com
-
rapt.com
-
connectbiopharm.com
-
eledon.com
-
medicago.com
-
perthbiodesign.com.au
-
canprevent.com
-
avitusortho.com
-
slanmedicinal.com
-
alkahest.com
-
ultragenyx.com
-
mediprintlens.com
-
polypid.com
-
audiontherapeutics.com
-
galtrx.com
-
metrixmedical.co.za
-
medearly.ie
-
vectivbio.com
-
gbsciences.com
Jubilant Therapeutics | Oncology | Autoimmune
As a patient-centric biopharmaceutical company, Jubilant Therapeutics leverages innovation to address unmet medical needs in oncology and autoimmune diseases.
Home - Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Incyte Biosciences UK | Biopharmaceutical Company | http://www.incytebiosciences.uk
Read about Incyte, an international biopharmaceutical company focused on creating proprietary therapeutics to meet serious unmet medical needs in oncology and other diseases.
Incyte Biosciences Canada | Biopharmaceutical Company | Incyte.ca
Read about Incyte, an international biopharmaceutical company focused on creating proprietary therapeutics to meet serious unmet medical needs in oncology and other diseases.
Egetis Therapeutics
Egetis is an innovative, unique, and integrated pharmaceutical **** development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan **** segment
Oncternal Therapeutics | Home
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
BioEclipse Therapeutics™ | NEXT GENERATION OF IMMUNOTHERAPY
BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
ON. TARGET MOLECULES BIOTECH INC - Therapeutic Solution For Cancer
O.TM Biotech is a company dedicated to Cancer Therapeutics. The Company has successfully designed, developed & synthesized an anticancer molecule which causes natural cell death, in several cancer cell lines in-vitro.
Arcturus Therapeutics
Arcturus Therapeutics is a clinical-stage messenger RNA medicines company focused on development and distribution of therapeutics for rare diseases & vaccines.
Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Home - AnaptysBio
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
InMed Pharmaceuticals - Developing Rare Cannabinoid Therapeutics
InMed is developing cannabinoid-based medications for diseases with high unmet needs. InMed is the leader in the therapeutic development of cannabinol, CBN.
Home - VTV Therapeutics
vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of **** administered small molecule **** candidates to fill significant unmet medical needs. vTv has a pipeline of internally discovered clinical **** candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders. To learn more about our science […]
Welcome - EffRx
EffRx Pharmaceuticals SA is a commercial-stage pharmaceutical company, based in Switzerland, that develops and commercializes prescription medications for specialty indications. The primary focus is on therapeutics for men and women with musculoskeletal, genitourinary and rare diseases. The business model centers around providing superior clinical and commercial value propositions for physicians, payers and patients. We address real, unmet medical needs and strive to improve patient outcomes.
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.
Author: Dr Rebecca Taub; M D
LogicBio Therapeutics - Pioneering Genetic Medicine
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare diseases. Learn More
Home | Algiax Pharmaceuticals GmbH
News – Events About Us Algiax Pharmaceuticals is a clinical-stage biotechnology company established in 2011. It is dedicated to the discovery and development of innovative products to treat diseases with a high unmet medical need. Algiax’ lead candidate AP-325 is a small-molecule GABAA receptor modulator in clinical development as a therapy for neuropathic pain. Next […]
Other sites like lumosa com tw
Targeting unmet medical needs
Auris Medical is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
QTVascular
QT Vascular is a global company that develops new and differentiated therapeutic solutions to address specific unmet clinical needs in the treatment of complex vascular disease. TriReme Medical, a subsidiary of QT Vascular, manufactures and distributes the Chocolate and Glider families of angioplasty balloons.
A regenerative therapy company - Bone Therapeutics
Bone Therapeutics is a bone cell therapy company specializing in addressing unmet medical needs in the field of bone fracture repair and bone fracture prevention. Bone Therapeutics develops both autologous and allogeneic innovative cell therapy products.
Author: Bone Therapeutics SA
Pharnext - Pharnext
Pharnext is an advanced clinical-stage biopharmaceutical company developing novel first-in-class therapies for orphan and common diseases with high unmet medical needs, leveraging our artificial intelligence (AI)-based PLEOTHERAPY™ platform.
Life Sciences Venture Capital Fostering new solutions for chronic diseases | Newton Biocapital
Newton Biocapital's approach is to support promising startup projects as well as neglected or undervalued late-stage life sciences companies in the "core of Europe" and Japan. We invest in therapeutic, diagnostic, medical device, clinical nutrition and digital biotech companies that share our…
mRNA Therapeutics for Genetic Disease | Translate Bio
Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat and prevent diseases caused by protein or gene dysfunction.
ABOUT US | Prilenia Therapeutics
Prilenia Therapeutics is a clinical stage biotech company developing its lead **** candidate, pridopidine, for Huntington’s Disease and ALS. It was founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.
Advancing Innovative Therapies | Summit Plc
We are a clinical-stage **** discovery and development company advancing innovative therapies to significantly advance the current standard of treatment for serious unmet medical needs.
Byondis | Creating Precision Medicines
We are a clinical stage biopharmaceutical research and development company with around 400 staff, including highly educated scientists and skilled technicians who share the same goal: To create safe and effective precision medicines targeting intractable cancers and autoimmune diseases, improving the standard of care for patients.
Breakthrough miRNA therapeutics tackling cancer - InteRNA Technologies
A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation **** delivery
Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing **** therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
Eledon Pharmaceuticals: Developing precision therapeutics that target the CD40 Ligand pathway
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing **** or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Developing novel vaccines and therapeutic proteins | Medicago
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
Perth Biodesign
Perth Biodesign is training the next generation of entrepreneurs in Western Australia to create real digital health and medical technology companies, based on real unmet clinical needs.
Home Page - Cancer Prevention
Cancer Prevention Pharmaceuticals is a clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases. CPP’s innovative technology addresses polyamine metabolism, immune regulation and inflammation to reduce cancer risk and impact other diseases. These … Continue reading →
Bone Graft Harvesting System | Osteomyelitis Debridement- Avitus Orthopaedics
Avitus® Orthopaedics is a medical device company dedicated to innovating game changing technology to solve unmet clinical needs. Suction curettage, autograft bone, bone harvest, etc. Visit Us!
SLAN
Slan Medicinal Holdings and group companies are part of a network of independent associated companies focused on improving patient health and addressing unmet medical needs by acquiring, developing, manufacturing and commercializing specialty pharmaceutical products in niche orphan disease and specialty segments.
Home - Alkahest
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and disease. Harnessing Chronokines Aging is the dominant risk factor in degenerative diseases, particularly those with no or few therapeutic solutions. Alkahest is decoding the plasma proteome to create …
Rare Genetic Diseases | Ultragenyx
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.
What else lumosa.com.tw alternative websites
Mediprint Lens | Helping Protect Sight with Innovative Eye Care Solutions
Helping Protect Sight with Innovative Eye Care Solutions MediPrint™ Ophthalmics (formerly Leo Lens Pharma) is an emerging San Diego-based clinical stage eye care pharmaceutical company developing and commercializing a proprietary ocular **** delivery portfolio. Learn More Unmet Needs Traditional eye drops
Author: Araceli Richardson
PolyPid - Optimized Therapeutics
ABOUT US We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications […]
Audion Therapeutics
Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss About Audion Hearing Loss Acquired Sensorineural Hearing Loss (SNHL), due to aging, exposure to noise or other environmental factors impacts hundreds of millions of people. According to the recently updated World Health Organization estimates, 1 in 4 people worldwide...
GALT Pharmaceuticals - Home
A unique pharmaceutical company, Galt has found a better way to enhance the quality of life of patients with products that meet unmet clinical needs, while creating life-changing opportunities for entrepreneurs, our employees and the individuals within the communities we serve.
Author: GALT Pharmaceuticals
Metrix Medical
Your Local Medical Technology Supplies Partner With 15 years of experience in the medical technology sector, we specialise in premium-quality solutions in the Pathology, Radiology, Oncology, Orthopaedics, Gynaecology, and Cardiology sectors. We apply leadership through innovation and the relentless pursuit of identifying unmet clinical needs. Excellence through service and delivery, that adds benefit to both patients ...
Home - MedEarly
“Delivering improved solutions to Irish clinicians, carers and patients.” MedEarly Healthcare’s focus is to address unmet clinical needs for Irish patients through representing International medical device manufacturing companies offering innovative and unique technologies in clinical areas where current treatments are sub-optimal.
Author: Admin
VectivBio | Transforming Lives
Life-Transforming Medicines for Patients Living with Severe Rare Diseases We are a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. Learn More About Us Our Focus We use a patient-centric approach to identify and develop transformative medicines for the treatment […]
Home - GB Sciences
THE FUTURE OF HEALING We are a dedicated plant-based research and biopharmaceutical **** development company. Our goal is to create patented formulations of plant-inspired, yet optimized therapeutic mixtures for use as prescription medications. LEARN MORE PARKINSON’S DISEASE THERAPIESWe achieved statistically significant results in our Animal...
